Package 71335-2807-1

{"route": ["ORAL"], "spl_id": "fe552468-ccc5-4362-b462-10fb7f10cf18", "openfda": {"nui": ["N0000185008", "N0000185007", "N0000182137", "N0000190114", "N0000185503"], "unii": ["MVR3JL3B2V"], "rxcui": ["1300791"], "spl_set_id": ["3bd73250-2b31-4b22-983b-15119846e697"], "pharm_class_epc": ["beta3-Adrenergic Agonist [EPC]"], "pharm_class_moa": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (71335-2807-1)  / 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "71335-2807-1", "marketing_start_date": "20250926"}], "brand_name": "MIRABEGRON", "product_id": "71335-2807_fe552468-ccc5-4362-b462-10fb7f10cf18", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "beta3-Adrenergic Agonist [EPC]"], "product_ndc": "71335-2807", "generic_name": "mirabegron", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MIRABEGRON", "active_ingredients": [{"name": "MIRABEGRON", "strength": "25 mg/1"}], "application_number": "ANDA209485", "marketing_category": "ANDA", "marketing_start_date": "20240419", "listing_expiration_date": "20261231"}